Refine Search
(1)
(4)
(4)
(4)

Personalized Medicine

GlobalData’s reports on Gene Therapies and Stem Cell therapies in CVMD and Oncology provide an overview of gene and stem cell therapies for the treatment of various cardiovascular and metabolic (CVMD), and oncology indications. The reports cover the competitive assessment of pipeline therapies, clinical trials mapping and design, pricing, reimbursement, regulatory strategy, and the analysis of market potential. The reports are driven by primary research (interviews of Key Opinion Leaders and payers) and provide a well-informed base for decision making.

Stem Cells in Neurology

  • $7,995
  • September 2018
Add to Basket Quick View Add to Saved List

Stem cells in neurology is an evolving field. The current pipeline of products feature different types of stem cells and these therapies have the potential to target a range of neurological diseases. However, there are challenges associated wit...

Gene Therapy in Oncology

  • $7,995
  • June 2018
Add to Basket Quick View Add to Saved List

Unlike conventional treatments such as chemotherapy, gene therapy combines reduced treatment duration (one time treatment in some cases) with higher chances of cure in oncology. This novel therapeutic approach requires direct delivery of geneti...

Stem Cell Therapies in CVMD

  • $7,995
  • June 2018
Add to Basket Quick View Add to Saved List

Regenerative medicine could potentially cure diseases and may replace palliative treatments for chronic diseases. Stem cells in particular have been studied for their regenerative properties: their potential to repair or replace damaged or dise...

Gene Therapy in CVMD

  • $7,995
  • June 2018
Add to Basket Quick View Add to Saved List

Gene therapies have been a point of discussion during the last several years as a potential curative option for a variety of disease indications. While mainly still in preclinical stages, gene therapy aims to treat or alleviate a disease by gen...